发明名称 FIBRIN SEALANT (FIBRINGLURAAS) CONSISTING OF A KIT OF LYOPHILIZED OR FROZEN HIGH CONCENTRATE FRIBINOGEN
摘要 The application is directed to a fibrin sealant (FIBRINGLURAAS®) consisting of a kit of lyophilized or frozen high concentrate fribinogen in which 5% a1at will be added into the final bulk and or 5% a1at as a diluent for high concentrate fibrinogen and new found proteins kh30, kh31, kh32, kh44, kh46, kh47, and kh52 in which the kh good healthy cells are present, either non-heated or heating to at least 1° C. and above, preferably at least 101° C., and lyophilized or frozen thrombin used to compound glue membrane, the diameter of which is less than 10 micrometers the actual size of the glue membrane of the fibrin sealant (FIBRINGLURAAS®) is from 0.6 μm, to 101° C. heating 0.005 micrometers and its topical applications for all solid tumor cancer
申请公布号 US2014287044(A1) 申请公布日期 2014.09.25
申请号 US201414151147 申请日期 2014.01.09
申请人 Rare Antibody Antigen Supply, Inc. 发明人 Hoang Kieu
分类号 A61K38/36;A61K38/48;A61K31/44 主分类号 A61K38/36
代理机构 代理人
主权项 1. A method of purifying fibrinogen from plasma Fraction I or from plasma cryoprecipate comprising: a) collecting plasma cryopaste or Fraction I from human plasma; b) dissolving the Fraction I or cryopaste acquired in step a) in a pretreatment buffer, and conducting SID virus inactivation for enveloped virus; c) loading the treated solution from step b) to a canion chromatography; d) using cold ethanol precipitation to purify fibrinogen from the flow through in step c); e) loading elution buffer I to obtain factor VIII; f) dissolving a paste generated in step d) by using Buffer II for final formulation; and g) dialyzing and adding a stabilizer in the bulk acquired in step f).
地址 Agoura Hills CA US